Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Evaluation of several micro RNA (miRNA) levels in children and adolescents with attention deficit hyperactivity disorder.

Kandemir H, Erdal ME, Selek S, Ay Öİ, Karababa IF, Kandemir SB, Ay ME, Yılmaz ŞG, Bayazıt H, Taşdelen B.

Neurosci Lett. 2014 Sep 19;580:158-62. doi: 10.1016/j.neulet.2014.07.060. Epub 2014 Aug 12.

PMID:
25123444
2.

Microribonucleic acid dysregulations in children and adolescents with obsessive-compulsive disorder.

Kandemir H, Erdal ME, Selek S, İzci Ay Ö, Karababa İF, Ay ME, Kandemir SB, Yılmaz ŞG, Ekinci S, Taşdelen B, Bayazit H.

Neuropsychiatr Dis Treat. 2015 Jul 14;11:1695-701. doi: 10.2147/NDT.S81884. eCollection 2015.

3.
4.

[Comparing the comorbidity of attention-deficit/hyperactivity disorder in childhood and adolescence].

Keresztény A, Dallos G, Miklósi M, Róka A, Gádoros J, Balázs J.

Psychiatr Hung. 2012;27(3):165-73. Hungarian.

PMID:
22781541
5.

Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.

Zwi M, Jones H, Thorgaard C, York A, Dennis JA.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD003018. doi: 10.1002/14651858.CD003018.pub3. Review.

PMID:
22161373
6.

The cognitive-energetic model: an empirical approach to attention-deficit hyperactivity disorder.

Sergeant J.

Neurosci Biobehav Rev. 2000 Jan;24(1):7-12. Review.

PMID:
10654654
7.

Evaluation of single nucleotide polymorphisms in the miR-183-96-182 cluster in adulthood attention-deficit and hyperactivity disorder (ADHD) and substance use disorders (SUDs).

Sánchez-Mora C, Ramos-Quiroga JA, Garcia-Martínez I, Fernàndez-Castillo N, Bosch R, Richarte V, Palomar G, Nogueira M, Corrales M, Daigre C, Martínez-Luna N, Grau-Lopez L, Toma C, Cormand B, Roncero C, Casas M, Ribasés M.

Eur Neuropsychopharmacol. 2013 Nov;23(11):1463-73. doi: 10.1016/j.euroneuro.2013.07.002. Epub 2013 Jul 29.

PMID:
23906647
8.

Increased levels of serum neopterin in attention deficit/hyperactivity disorder (ADHD).

Ceylan MF, Uneri OS, Guney E, Ergin M, Alisik M, Goker Z, Senses Dinc G, Karaca Kara F, Erel O.

J Neuroimmunol. 2014 Aug 15;273(1-2):111-4. doi: 10.1016/j.jneuroim.2014.06.002. Epub 2014 Jun 14.

PMID:
24969118
9.

Zinc, ferritin, magnesium and copper in a group of Egyptian children with attention deficit hyperactivity disorder.

Mahmoud MM, El-Mazary AA, Maher RM, Saber MM.

Ital J Pediatr. 2011 Dec 29;37:60. doi: 10.1186/1824-7288-37-60.

10.
11.

Psychiatric comorbidity among children and adolescents with and without persistent attention-deficit hyperactivity disorder.

Gau SS, Ni HC, Shang CY, Soong WT, Wu YY, Lin LY, Chiu YN.

Aust N Z J Psychiatry. 2010 Feb;44(2):135-43. doi: 10.3109/00048670903282733.

PMID:
20113302
12.

Serum nerve growth factor (NGF) levels in children with attention deficit/hyperactivity disorder (ADHD).

Guney E, Ceylan MF, Kara M, Tekin N, Goker Z, Senses Dinc G, Ozturk O, Eker S, Kizilgun M.

Neurosci Lett. 2014 Feb 7;560:107-11. doi: 10.1016/j.neulet.2013.12.026. Epub 2013 Dec 19.

PMID:
24361544
13.

Regulating the Regulators in Attention-Deficit/Hyperactivity Disorder: A Genetic Association Study of microRNA Biogenesis Pathways.

Karakas U, Ay OI, Ay ME, Wang W, Sungur MA, Çevik K, Dogru G, Erdal ME.

OMICS. 2017 Jun;21(6):352-358. doi: 10.1089/omi.2017.0048. Epub 2017 May 30.

PMID:
28557556
14.

Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB.

Ribasés M, Ramos-Quiroga JA, Hervás A, Bosch R, Bielsa A, Gastaminza X, Artigas J, Rodriguez-Ben S, Estivill X, Casas M, Cormand B, Bayés M.

Mol Psychiatry. 2009 Jan;14(1):71-85. Epub 2007 Oct 16.

PMID:
17938636
15.

Is there a relationship between attention deficit/hyperactivity disorder and manic symptoms among children with mental retardation of unknown etiology?

Fidan T, Kirpinar I, Oral M, Koçak K.

Compr Psychiatry. 2011 Nov-Dec;52(6):644-9. doi: 10.1016/j.comppsych.2010.11.007. Epub 2011 Feb 9.

PMID:
21310401
16.

Evaluating physical activity using accelerometry in children at risk of developmental coordination disorder in the presence of attention deficit hyperactivity disorder.

Baerg S, Cairney J, Hay J, Rempel L, Mahlberg N, Faught BE.

Res Dev Disabil. 2011 Jul-Aug;32(4):1343-50. doi: 10.1016/j.ridd.2011.02.009. Epub 2011 Mar 21.

PMID:
21420277
17.
18.

[Diagnostic value of Vanderbilt ADHD Parent Rating Scale in attention deficit hyperactivity disorder].

Xiao ZH, Wang QH, Luo TT, Zhong L.

Zhongguo Dang Dai Er Ke Za Zhi. 2013 May;15(5):348-52. Chinese.

19.

[The course of attention deficit hyperactivity disorder (ADHD) over the life span].

Koumoula A.

Psychiatriki. 2012 Jun;23 Suppl 1:49-59. Review. Greek, Modern.

PMID:
22796973
20.

Substance use disorders in adolescents with attention deficit hyperactivity disorder: a 4-year follow-up study.

Groenman AP, Oosterlaan J, Rommelse N, Franke B, Roeyers H, Oades RD, Sergeant JA, Buitelaar JK, Faraone SV.

Addiction. 2013 Aug;108(8):1503-11. doi: 10.1111/add.12188. Epub 2013 Apr 22.

PMID:
23506232

Supplemental Content

Support Center